The AI trade has had favorites. NVIDIA, Microsoft, Alphabet, and Meta have carried the narrative, while two enterprise tech giants have quietly compounded earnings and built backlogs that few retail investors are talking about. With the S&P 500 up 8% year to date, the setup for these laggards looks asymmetric heading into the back half of 2026.
Our criteria: large-cap enterprise tech with credible AI revenue streams, recent price action lagging the broader market, and a fundamental catalyst path that could re-rate the stock. Two names jumped out. We are counting down to the one we think has the most coiled spring.
#2. Oracle (NYSE: ORCL)
Oracle (NYSE:ORCL | ORCL Price Prediction) has gone nowhere in 2026. Shares are down 6% year to date, even as the operating story has gotten dramatically better.
In Q3 FY2026, Oracle posted revenue of $17.19 billion and EPS of $1.79, marking the first quarter in over 15 years with organic total revenue and non-GAAP EPS both growing 20% or better. Cloud Infrastructure revenue hit $4.89 billion, up 84% year over year, with AI infrastructure revenue specifically up 243%.
The forward signal is the backlog. Remaining Performance Obligations swelled to $553 billion, a 325% jump year over year. Safra Catz has guided Oracle Cloud Infrastructure revenue from $18 billion in FY2026 to $144 billion within five years, with most of that already booked in RPO. Multicloud database revenue grew 531% year over year, and co-CEO Clay Magouyrk noted that “demand for AI infrastructure, both GPU and CPU, continues to exceed supply.”
The catch is capital intensity. CapEx is running at roughly $50 billion, free cash flow is negative, and non-current debt sits at $124.7 billion. Analysts remain constructive, with 35 buys, 8 holds, and 1 sell and a consensus target of $242.74. The market is waiting for capex to translate to cash flow.
#1. IBM (NYSE: IBM)
IBM (NYSE:IBM) is the bigger setup. Shares are down 24% year to date and 15% over the past year, while fundamentals have quietly accelerated.
Q1 2026 marked IBM’s fourth consecutive EPS beat. EPS came in at $1.91 versus $1.81 expected, on revenue of $15.92 billion, up 9% year over year. The mainframe business, long considered legacy ballast, is in a refresh cycle: IBM Z revenue surged 51% in Q1, following 67% growth in Q4 2025. Infrastructure segment profit margin expanded to 16% from 9% a year ago.
The AI story is real and monetizing. IBM’s generative AI book of business exited 2025 at more than $12.5 billion inception-to-date, with roughly four-fifths coming from Consulting. GenAI now represents about 30% of consulting backlog, and CEO Arvind Krishna noted that “IBM Bob, our AI-based software development system, is now generally available. Our entire developer workforce is using Bob with average productivity gains of 45%.”
Krishna framed the demand picture directly: “As clients scale use cases, AI continues to be a tailwind for our global business. IBM products and services are helping clients orchestrate, deploy and govern AI across hybrid environments.” The Red Hat franchise grew 13% in Q1, and the May 2026 partnership expansion with Oracle puts Red Hat Enterprise Linux directly inside OCI, opening a fresh distribution channel.
For retirement-focused investors, the floor is the dividend. IBM just raised its quarterly payout to $1.69 per share, the 31st consecutive year of dividend increases. The stock trades at a P/E of 19x, with an analyst consensus target of $278.18 and insiders net buying. Full-year guidance calls for 5%+ constant currency revenue growth and roughly $1 billion of incremental free cash flow.
The Setup From Here
The dormant giants thesis is straightforward. Oracle has headline growth and a $553 billion backlog, but also debt and a capex bill. IBM has the better risk-adjusted setup: an installed base printing cash, a mainframe cycle running hot, an AI book scaling toward meaningful revenue share, and a stock punished against a climbing S&P 500. If consulting growth re-accelerates or the AI book continues compounding into the back half of 2026, the disconnect between IBM’s price action and operating results will be hard for the market to ignore. Keep an eye on the stock through the next earnings cycle.